Αποτελέσματα Αναζήτησης
Similarly, the prevalence of gastric ulcer (GU) decreased from 11.9% to 9.4% (p < 0.001). 3. In the Philippines, peptic ulcer prevalence decreased significantly over a seven-year period, i.e., from 35.87% in 1996 to 18.80% in 2002; although the prevalence of peptic ulcer bleeding remained stable. This decline was noted
practice guidelines for peptic ulcer disease in 2020 and created an English version. The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter pylori (H. pylori) eradica-tion therapy, non-eradication therapy, drug-induced ulcers, non-H. pylori, and nonsteroidal anti-inflammatory drug
23 Φεβ 2021 · The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter pylori ( H. pylori ) eradication therapy, non-eradication therapy, drug-induced...
23 Φεβ 2021 · The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter pylori (H. pylori) eradication therapy, non-eradication therapy, drug-induced ulcers, non-H. pylori, and nonsteroidal anti-inflammatory drug (NSAID) ulcers, remnant gastric ulcers, surgical treatment, and conservative therapy for ...
23 Φεβ 2021 · The revised guidelines consist of nine items: epidemiology, hemorrhagic gastric and duodenal ulcers, Helicobacter pylori (H. pylori) eradication therapy, non-eradication therapy, drug-induced ulcers, non-H. pylori, and nonsteroidal anti-inflammatory drug (NSAID) ulcers, remnant gastric ulcers, surgical treatment, and conservative therapy for ...
7 Ιαν 2020 · We divided our work into the two main topics, bleeding and perforated peptic ulcer, and structured it into six main topics that cover the entire management process of patients with complicated peptic ulcer, from diagnosis at ED arrival to post-discharge antimicrobial therapy, to provide an up-to-date, easy-to-use tool that can help physicians ...
This document presents the Philippine Consensus Statements on the Management of Non-Variceal Upper Gastrointestinal Bleeding from 2012. It was developed by a group of gastroenterologists and surgeons from various institutions in the Philippines.
